Cargando…
Calcium dysregulation in atrial fibrillation: the role of CaMKII
Atrial fibrillation (AF) is the most frequently encountered clinical arrhythmia and is associated with increased morbidity and mortality. Ectopic activity and reentry are considered major arrhythmogenic mechanisms contributing to the initiation and maintenance of AF. In addition, AF is self-reinforc...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3940963/ https://www.ncbi.nlm.nih.gov/pubmed/24624086 http://dx.doi.org/10.3389/fphar.2014.00030 |
_version_ | 1782305845291253760 |
---|---|
author | Heijman, Jordi Voigt, Niels Wehrens, Xander H. T. Dobrev, Dobromir |
author_facet | Heijman, Jordi Voigt, Niels Wehrens, Xander H. T. Dobrev, Dobromir |
author_sort | Heijman, Jordi |
collection | PubMed |
description | Atrial fibrillation (AF) is the most frequently encountered clinical arrhythmia and is associated with increased morbidity and mortality. Ectopic activity and reentry are considered major arrhythmogenic mechanisms contributing to the initiation and maintenance of AF. In addition, AF is self-reinforcing through progressive electrical and structural remodeling which stabilize the arrhythmia and make it more difficult to treat. Recent research has suggested an important role for Ca(2+)-dysregulation in AF. Ca(2+)-handling abnormalities may promote ectopic activity, conduction abnormalities facilitating reentry, and AF-related remodeling. In this review article, we summarize the Ca(2+)-handling derangements occurring in AF and discuss their impact on fundamental arrhythmogenic mechanisms. We focus in particular on the role of the multifunctional Ca(2+)/calmodulin-dependent protein kinase type-II (CaMKII), which acts as a major link between Ca(2+)-dysregulation and arrhythmogenesis. CaMKII expression and activity are increased in AF and promote arrhythmogenesis through phosphorylation of various targets involved in cardiac electrophysiology and excitation-contraction coupling. We discuss the implications for potential novel therapeutic strategies for AF based on CaMKII and Ca(2+)-handling abnormalities. |
format | Online Article Text |
id | pubmed-3940963 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-39409632014-03-12 Calcium dysregulation in atrial fibrillation: the role of CaMKII Heijman, Jordi Voigt, Niels Wehrens, Xander H. T. Dobrev, Dobromir Front Pharmacol Pharmacology Atrial fibrillation (AF) is the most frequently encountered clinical arrhythmia and is associated with increased morbidity and mortality. Ectopic activity and reentry are considered major arrhythmogenic mechanisms contributing to the initiation and maintenance of AF. In addition, AF is self-reinforcing through progressive electrical and structural remodeling which stabilize the arrhythmia and make it more difficult to treat. Recent research has suggested an important role for Ca(2+)-dysregulation in AF. Ca(2+)-handling abnormalities may promote ectopic activity, conduction abnormalities facilitating reentry, and AF-related remodeling. In this review article, we summarize the Ca(2+)-handling derangements occurring in AF and discuss their impact on fundamental arrhythmogenic mechanisms. We focus in particular on the role of the multifunctional Ca(2+)/calmodulin-dependent protein kinase type-II (CaMKII), which acts as a major link between Ca(2+)-dysregulation and arrhythmogenesis. CaMKII expression and activity are increased in AF and promote arrhythmogenesis through phosphorylation of various targets involved in cardiac electrophysiology and excitation-contraction coupling. We discuss the implications for potential novel therapeutic strategies for AF based on CaMKII and Ca(2+)-handling abnormalities. Frontiers Media S.A. 2014-03-04 /pmc/articles/PMC3940963/ /pubmed/24624086 http://dx.doi.org/10.3389/fphar.2014.00030 Text en Copyright © 2014 Heijman, Voigt, Wehrens and Dobrev. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Heijman, Jordi Voigt, Niels Wehrens, Xander H. T. Dobrev, Dobromir Calcium dysregulation in atrial fibrillation: the role of CaMKII |
title | Calcium dysregulation in atrial fibrillation: the role of CaMKII |
title_full | Calcium dysregulation in atrial fibrillation: the role of CaMKII |
title_fullStr | Calcium dysregulation in atrial fibrillation: the role of CaMKII |
title_full_unstemmed | Calcium dysregulation in atrial fibrillation: the role of CaMKII |
title_short | Calcium dysregulation in atrial fibrillation: the role of CaMKII |
title_sort | calcium dysregulation in atrial fibrillation: the role of camkii |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3940963/ https://www.ncbi.nlm.nih.gov/pubmed/24624086 http://dx.doi.org/10.3389/fphar.2014.00030 |
work_keys_str_mv | AT heijmanjordi calciumdysregulationinatrialfibrillationtheroleofcamkii AT voigtniels calciumdysregulationinatrialfibrillationtheroleofcamkii AT wehrensxanderht calciumdysregulationinatrialfibrillationtheroleofcamkii AT dobrevdobromir calciumdysregulationinatrialfibrillationtheroleofcamkii |